Eos Advisory
Impact investorSt Andrews · Seed–Growth · 10 people tracked
Also known as Kinburn (209) Llp
Investment thesis
Eos acts as a link between non-specialist investors and science- and technology-intensive companies. Its portfolio spans quality of life and environmental sustainability, covering disease diagnostics, prevention and treatment, food and water security, pollution reduction, clean energy and sustainable infrastructure. The firm seeks commensurate financial returns from early-stage patient capital while backing businesses that generate positive impact. Eos works in long-term partnerships with family offices, individuals, companies and institutional investors, operating across seed and growth stages on a managed or discretionary basis, from multistage multiyear relationships to angel syndicates. It offers S/EIS UK tax relief to eligible investors when available and is committed to diversity and inclusion.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's websiteWhat they invest in
from 17 of 22 portfolio companiesBiotech ×9Healthtech ×9Medical Devices ×7Cleantech ×5Deep Tech ×5AI & Machine Learning ×3Hardware ×3New Materials ×3
HQs:United Kingdom×9Italy×1
Investments · 22 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 23 dated
Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to more patients.
Digital HealthMedical DevicesRobotics
Biotangents develops AmpliSpec, a LAMP-based molecular diagnostics platform for veterinary use that delivers pathogen-specific results in under two hours at the point of care, in laboratories, or embedded within partner systems.
AgTechBiotechMedical Devices
Carcinotech produces 3D-bioprinted tumour models using established cancer cell lines and patient-derived tissue, offering assay-ready models and preclinical oncology services for drug testing and translational research.
BiotechDeep TechHealthtechScotland
Albert Nicholl(Director)Ishani Malhotra(Executive Officer, Director)Ian David Waddell(Director)
Concinnity Genetics develops control mechanisms to improve the safety of cell and gene therapies, using an AI platform and synthetic biology to help biopharmaceutical partners design and optimise their gene therapies.
AI & Machine LearningBiotechHealthtechEdinburgh, GB
Jessica Birt(Co-founder & CEO)Matthew Dale(Co-founder & CSO)
Cumulus Oncology builds a risk-adjusted portfolio of preclinical-stage oncology drug assets, using a platform-agnostic, data- and milestone-driven curation process to advance cancer therapeutics for defined patient populations with high unmet medical need.
BiotechHealthtech
Clare Wareing(CEO)
Dxcover develops a multi-omic liquid biopsy platform that combines infrared light spectroscopy and machine learning to detect multiple cancers at an early stage.
AI & Machine LearningBiotechMedical Devices
ENOUGH produces sustainable food ingredients and works with customers, suppliers, and partners toward its mission.
FoodTechImpact & Social Good
EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration.
BiotechCleantechDeep TechHealthtechMedical Devices
Asel Sartbaeva(Co-Founder & CEO)Matt Slade(Co-Founder & Chief of Staff)Stephen Wells(Co-Founder & Advisor)Aswin Doekhie(Co-Founder & CTO)Sabine Ficek(CFO)Simon Bennett(Chief Commercial Officer)
ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform.
BiotechDeep TechHealthtechMedical Devices
Owain Millington(CEO)
Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains.
HealthtechMedical DevicesRoboticsGlasgow, GB
Nico Fenu(Co-Founder & Chief Operating Officer)REBECCA CLEARY(Executive Officer, Director)NICOLA GIUSEPPE FENU(Executive Officer, Director)NIKKI PAMELA PALFREY(Director)ALBERT NICHOLL(Director)Rebecca Cleary(Co-Founder & Chief Technical Officer)
Naturbeads develops biodegradable cellulose microspheres to replace microplastics in consumer products such as cosmetics and paints.
Circular EconomyCleantechNew MaterialsItaly, IT
Marco Meuli(Operator)Janet Scott(Co-founder)Davide Mattia(Co-founder)Giovanna Laudisio(Co-founder)
Developed technology embedding pure silver particles into fibres as an ecologically sound, non-toxic antimicrobial coating for paints and textiles.
SILVERbac is a patented antimicrobial textile technology that permanently incorporates pure silver particles into fibres, making the treatment non-leaching, non-toxic, and eco-friendly.
Advanced ManufacturingCleantechHealthtechNew MaterialsDubai, GB
Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.
BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh
Joanna Smart(Director)Richard Izen Kuo(Executive Officer, Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)
Portfolio news
latest coverage across their companiesChemify · soci.org · Jan 27, 2026
Principals & officers · per Companies House
what is this? ⓘLLP designated member · since 2022
LLP designated member · since 2018
LLP member · since 2020
LLP member · since 2019
LLP member · since 2019
Andrew Paul Mcneill — 25–50% of voting rights, right to share surplus assets 25 to 50 percent limited liability partnership
Frequently asked questions
- What stage does Eos Advisory invest at?
- Eos Advisory invests at the Seed, Series A, Growth stages.
- What sectors does Eos Advisory focus on?
- Eos Advisory focuses on AgTech, Biotech, Cleantech, Climate Tech, Deep Tech, Digital Health, Energy, FoodTech, Healthtech, Impact & Social Good, IoT, Medical Devices.
- Where is Eos Advisory located?
- Eos Advisory is headquartered in St Andrews, GB.
- Does Eos Advisory lead rounds?
- Eos Advisory typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamSimilar investors
BDC Capital's venture capital arm makes fund investments, and is a limited partner in Amplitude Ventures' Fund I. This page profiles Amplitude Ventures, a portfolio fund.
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
Qbic is an inter-university venture capital fund that turns technological breakthroughs from its partner universities, research institutes and hospitals into sustainable businesses.
MDI Ventures is the corporate venture capital arm of Indonesia's Telkom Group, investing in technology startups and emphasizing measurable social and environmental impact alongside financial returns.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.









